about
Reliability of Frozen Section Examination in a Large Cohort of Testicular Masses: What Did We Learn?Robot-Assisted Vesico-Vaginal Fistula Repair: Our Technique and Review of the Literature.Long-term results of a prospective randomized trial assessing the impact of re-adaptation of the dorsolateral peritoneal layer after extended pelvic lymph node dissection and cystectomy.Outcomes of robot-assisted simple enucleation of renal masses: A single European center experienceOncological and functional outcomes of postoperative total parenteral nutrition after radical cystectomy in bladder cancer patients: A single-center randomized trial.Robot-assisted partial nephrectomy: systematic review of functional results.Oncologic outcomes after minimally invasive surgery for cT1 renal masses: a comprehensive review.Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer Center.Robotic assisted simple prostatectomy: recent advances.The impact of moderate wine consumption on the risk of developing prostate cancer.Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors.Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder CancerHigh-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional StudyNeutrophil, Platelets, and Eosinophil to Lymphocyte Ratios Predict Gleason Score Upgrading in Low-Risk Prostate Cancer PatientsPrognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysisComparison Between 64Cu-PSMA-617 PET/CT and 18F-Choline PET/CT Imaging in Early Diagnosis of Prostate Cancer Biochemical RecurrenceAn increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancerPredictors of Residual T1 High Grade on Re-Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder CancerIncidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trialsRole of serum cholinesterase in patients treated with salvage radical prostatectomyPrognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder CancerPrognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladderPrognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancerPrognostic Value of Concomitant Carcinoma In Situ in the Radical Cystectomy Specimen: A Systematic Review and Meta-AnalysisPositive Pre-cystectomy Biopsies of the Prostatic Urethra or Bladder Neck Do Not Necessarily Preclude Orthotopic Bladder SubstitutionLong-term oncologic and functional outcomes after robot-assisted partial nephrectomy in elderly patientsSystemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder CancerImpact of alcohol consumption on the risk of developing bladder cancer: a systematic review and meta-analysisMetabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an updateAbsolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumorClinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomyHigh-throughput detection of low abundance sialylated glycoproteins in human serum by TiO2 enrichment and targeted LC-MS/MS analysis: application to a prostate cancer sample set
P50
Q38952903-FD303B13-BC87-45ED-A5FC-4254BA282CE5Q39457760-74F4FA8F-1F39-4406-BE11-562472196E7FQ41749023-323C8979-69FC-4420-B066-68715E8DF9B5Q42288849-02C3F343-7259-4C9C-B74E-3A3A417EFCADQ47655843-A156087A-3DDA-4CDA-A17C-2C45B282F8BAQ49572949-A3A5379F-4A4C-4501-A398-20A9418B7E81Q49572966-440E0E57-81BD-41C4-8303-89037A0B2C30Q50126668-47574033-514F-4D64-A483-6EF02AF06054Q50419823-27C4CC6C-0608-469E-A7CE-49F6AB86BE0AQ52715355-3670809F-A3BA-4C86-BF44-1690F878E8FBQ52718601-955727B1-2CEE-4704-8BDD-CAEAE274E1A8Q56371409-885D64F3-76A2-47C2-B847-C4F7EF7F4149Q56927675-49227480-97E4-4AFB-8B95-32AAAB5FDA6CQ58590944-73F4C4FF-10E0-4771-822B-BA7AE0BF1AB1Q89045833-8ACB57EC-4F79-4E3F-B903-4E6A41A4D2D7Q89221847-454549CA-EB9E-40AE-B003-61BB112B442BQ89542896-813E3ED8-42B4-4B6C-A1CF-EA6D5BB01489Q90290657-F5EA9713-1A10-4ED4-AB48-240F1FBB41BEQ90293688-E8235CA0-753D-47F8-9187-212BDF0BEEF3Q90315155-7022BC9C-2619-4572-9200-E6F30AB8C70DQ90643510-9836E39E-1E38-43FB-8EB9-6236096CA28BQ90709729-9672FE83-4E83-4659-BC2F-94962F96E702Q90726245-04A843FC-FECE-4C8A-BD9F-2A66CA85C8C5Q90754536-31E47B98-0924-49D2-A878-9077734236B3Q91266626-452F5682-E1FF-4E5D-99ED-75D5CA9B194FQ91535470-A832D984-608F-4F70-B2DA-F8FC2165C067Q92487302-DB6A9787-F51A-4171-A7B4-D16680E78A1AQ92575460-1CD65E8A-68BC-4953-B194-5D50B1D9D7FAQ92919195-7F5F6B77-3BEB-4D50-9D6A-A92CD098D72BQ93143796-8679BFE3-AB18-4D7E-911F-82EE618C2087Q93182737-4DB0D99C-0756-45E6-BCA4-079EEB5286C2Q93357920-66F1F60F-E701-451B-B03E-F378E29F4911
P50
description
researcher
@en
wetenschapper
@nl
name
Mihai Dorin Vartolomei
@en
Mihai Dorin Vartolomei
@nl
type
label
Mihai Dorin Vartolomei
@en
Mihai Dorin Vartolomei
@nl
prefLabel
Mihai Dorin Vartolomei
@en
Mihai Dorin Vartolomei
@nl
P31
P496
0000-0002-0359-8517